Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645. State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654. Viewpoint Jan 2019 How Should Health Professionals and Policy Makers Respond to Substandard Care of Detained Immigrants? Rie Ohta and Clara Long, JD, MSc, MA Medical-legal partnerships can help detainees by motivating health, safety, and human rights standards in detention centers. AMA J Ethics. 2019;21(1):E113-118. doi: 10.1001/amajethics.2019.113. State of the Art and Science May 2020 How Will Artificial Intelligence Affect Patient-Clinician Relationships? Matthew Nagy, MPH and Bryan Sisk, MD AI might improve patient-clinician relationships, but various underlying assumptions will need to be addressed to bring these potential benefits to fruition. AMA J Ethics. 2020;22(5):E395-400. doi: 10.1001/amajethics.2020.395. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603. Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609. Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701. Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page Next › Last page Last »
State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645.
State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654.
Viewpoint Jan 2019 How Should Health Professionals and Policy Makers Respond to Substandard Care of Detained Immigrants? Rie Ohta and Clara Long, JD, MSc, MA Medical-legal partnerships can help detainees by motivating health, safety, and human rights standards in detention centers. AMA J Ethics. 2019;21(1):E113-118. doi: 10.1001/amajethics.2019.113.
State of the Art and Science May 2020 How Will Artificial Intelligence Affect Patient-Clinician Relationships? Matthew Nagy, MPH and Bryan Sisk, MD AI might improve patient-clinician relationships, but various underlying assumptions will need to be addressed to bring these potential benefits to fruition. AMA J Ethics. 2020;22(5):E395-400. doi: 10.1001/amajethics.2020.395.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603.
Viewpoint Sep 2016 The Limits of Informed Consent for an Overwhelmed Patient: Clinicians’ Role in Protecting Patients and Preventing Overwhelm Johan Bester, MBChB, MPhil, Cristie M. Cole, JD, and Eric Kodish, MD Protecting patients rather than informed consent should be the goal when the complexity of information overwhelms patients’ decision-making capacity. AMA J Ethics. 2016;18(9):869-886. doi: 10.1001/journalofethics.2016.18.9.peer2-1609.
Viewpoint Jan 2017 Should US Physicians Support the Decriminalization of Commercial Sex? Emily F. Rothman, ScD The Nordic model policy option for addressing commercial sex—which exempts sellers from criminal penalties—offers several potential advantages. AMA J Ethics. 2017;19(1):110-121. doi: 10.1001/journalofethics.2017.19.1.sect1-1701.
Viewpoint Jan 2017 Decreasing Human Trafficking through Sex Work Decriminalization Erin Albright, JD and Kate D'Adamo, MA Decriminalization of the sex trade speaks to medical ethics by reducing sex workers’ vulnerability to violence, exploitation, stigma, and trafficking. AMA J Ethics. 2017;19(1):122-126. doi: 10.1001/journalofethics.2017.19.1.sect2-1701.